The main compound patent covering the active ingredient tirzepatide is set to expire in 2036
Larsen GL, White CW, Takeda K, Loader JE, Nguyen DD, et al: Mice that over express Cu = Zn superoxide dismutase are resistant to allergen-induced changes in airway control
Related Reading Tirzepatide For Weight Loss 2 Tirzepatide Vs Semaglutide For Weight Loss Tirzepatide For Weight Loss Tirzepatide Weight Loss Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
coli (Vazyme
The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript